14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jul 08, 2021 $183.31 $183.96 $182.00 $183.40 5 822 592
Jul 07, 2021 $184.50 $184.76 $183.52 $184.27 2 755 884
Jul 06, 2021 $185.76 $186.35 $184.35 $184.54 3 380 343
Jul 02, 2021 $185.00 $186.52 $184.47 $186.28 1 290 007
Jul 01, 2021 $183.87 $185.37 $183.44 $185.10 1 338 994
Jun 30, 2021 $184.53 $184.59 $183.18 $183.71 1 601 527
Jun 29, 2021 $183.96 $185.01 $183.81 $184.30 1 166 948
Jun 28, 2021 $183.76 $185.11 $183.06 $184.14 1 139 122
Jun 25, 2021 $181.40 $182.96 $181.33 $182.74 2 291 311
Jun 24, 2021 $180.50 $182.23 $180.35 $180.72 1 793 543
Jun 23, 2021 $180.69 $181.53 $179.37 $179.83 1 525 074
Jun 22, 2021 $180.67 $180.68 $179.15 $179.63 1 027 188
Jun 21, 2021 $180.49 $181.15 $180.16 $180.66 2 081 706
Jun 18, 2021 $178.89 $181.74 $178.50 $180.69 3 910 840
Jun 17, 2021 $179.44 $180.85 $179.44 $179.97 1 499 245
Jun 16, 2021 $182.02 $183.05 $180.19 $180.55 2 213 534
Jun 15, 2021 $182.11 $182.17 $181.28 $181.90 904 031
Jun 14, 2021 $181.74 $182.20 $180.84 $181.65 2 251 688
Jun 11, 2021 $181.95 $182.72 $181.21 $181.65 1 306 386
Jun 10, 2021 $179.75 $182.11 $179.75 $181.99 1 177 489
Jun 09, 2021 $176.93 $179.37 $176.93 $179.18 1 702 888
Jun 08, 2021 $177.00 $177.29 $175.54 $176.61 1 046 247
Jun 07, 2021 $176.88 $177.90 $175.71 $176.28 3 283 349
Jun 04, 2021 $176.46 $177.82 $176.33 $177.12 1 363 255
Jun 03, 2021 $174.81 $176.02 $174.72 $175.78 2 265 938
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT